Mutual Fund Details

WhiteOak Capital Pharma and Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹13.1260

as on 28 Nov 2024, 11:20 PM

₹-0.0780(0.59%)

Last Change

Investment Performance

would have given a return of

₹1,00,875

₹1,01,687

₹1,03,678

₹1,04,133

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹4,133

Profit (absolute return)

4.13%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

4.13%

In the last 6 months

29.02%

In the last 1 year

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

WhiteOak Capital Pharma and Healthcare Fund Direct - Growth

as of 31 Oct 2024, 05:30 AM

₹231.99 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1%, if redeemed within 1 months.

0.68%

Expense Ratio

Plan

Growth

-11.93%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 1%, if redeemed within 1 months.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

96.81%

₹224.59 Cr

Materials

1.06%

₹2.45 Cr

Services

1.00%

₹2.31 Cr

Others

1.14%

₹2.64 Cr

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

96.81%

₹224.59 Cr

Materials

1.06%

₹2.45 Cr

Services

1.00%

₹2.31 Cr

Others

1.14%

₹2.64 Cr

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

9.11%

₹21.13 Cr

Cipla Ltd.

7.69%

₹17.84 Cr

Torrent Pharmaceuticals Ltd.

6.05%

₹14.04 Cr

Max Healthcare Institute Ltd.

5.86%

₹13.59 Cr

Zydus Lifesciences Ltd.

5.52%

₹12.81 Cr

Others

65.77%

₹152.58 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

9.11%

₹21.13 Cr

Cipla Ltd.

7.69%

₹17.84 Cr

Torrent Pharmaceuticals Ltd.

6.05%

₹14.04 Cr

Max Healthcare Institute Ltd.

5.86%

₹13.59 Cr

Zydus Lifesciences Ltd.

5.52%

₹12.81 Cr

Others

65.77%

₹152.58 Cr

View All

Funds in this Category

This fund's returns:

4.13%

Return Duration

3 Months

DSP Healthcare Fund Direct - Growth

LIC MF Healthcare Fund Direct - Growth

HDFC Pharma And Healthcare Fund Direct - Growth

About WhiteOak Capital Pharma and Healthcare Fund Direct - Growth

WhiteOak Capital Pharma and Healthcare Fund Direct - Growth is a Equity mutual fund scheme from WhiteOak Capital Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹231.99 Crores and the latest NAV decalared is ₹13.126 as on 29 Nov 2024 at 10:20 am.

WhiteOak Capital Pharma and Healthcare Fund Direct - Growth scheme return performance is 30.31% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.